Summit Partners has invested in Hallmark Health Care Solutions, according to a news release.

Hallmark, based in Hauppauge, N.Y., is a healthcare consulting and technology firm. The software-as-a-service (SaaS) company offers physician compensation and workforce management solutions for health systems, academic medical centers and physician groups.

Summit, based in Boston, pursues opportunities

On 26 October 2023, the Economic Crime and Corporate Transparency Act received royal assent. The new law is designed to fight corruption, money laundering and fraud, and has major implications for businesses, including:

  • The creation of a new “failure to prevent fraud” offence, imposing criminal liability on large organisations for wrongdoing committed by staff, agents
  • On this episode of The Professor’s CornerDiwakar Sinha of Polaris Healthcare Partners joins McGuireWoods’ Geoff Cockrell to discuss how practices can prepare to sell, what specialties are most attractive and how the search for investors varies from practice to practice.

    According to Diwakar, the same volume of deals is occurring, but the number

    The U.S. Department of Health and Human Services (HHS) Office of Research Integrity (ORI) released a notice of proposed rulemaking to update the 2005 Public Health Service (PHS) Policies on Research Misconduct. HHS seeks public comments on the proposal through Dec. 5, 2023.

    ORI expects the proposed changes to be effective Jan. 1, 2025. If

    September was an active month for Ponzi litigation with nearly a dozen new complaints filed alleging fraudulent investment activity. The SEC continues to drive Ponzi-related litigation; in addition to four enforcement actions brought last month, previous SEC litigation precipitated several complaints filed by investors and court-appointed receivers. Consistent with the trends discussed in Ponzi Perspective’s Midyear Roundup, the majority of actions filed in September involved real estate investment schemes and targeted solicitation of affinity groups.

    Notable litigation filed in September 2023 includes: (1) Conlan v. Roach, et al.; (2) Reispec Develop. LLC v. Pina, et al.; (3) Dottore v. SDR Realty; (4) SEC v. Kubler, et al.; (5) McGrath v. Palowet Inv., LLC; (6) SEC v. Feloni, et al.; (7) SEC v. Aras Inv. Bus. Grp., et al.; (8) American Eagle Oil & Gas Co., et al. v. Navarro Prod. Co., et al.; (9) Luppino v. Spano, et al.; and (10) SEC v. Motil, et al.

    McGuireWoods recently held its 16th annual Healthcare Finance & Growth Conference, during which speakers and industry leaders examined various subtopics in the healthcare space.

    During the conference, Jeremy Johnson, Senior Managing Director, Head of Investment Banking at Bourne Partners, and Jeff Edwards, a partner at QHP Capital, participated in an afternoon panel discussion of current

    On this episode of The Banker’s Corner, McGuireWoods’ Geoff Cockrell talks to Craig Sager, director at Provident Healthcare Partners, about investing in primary care.

    Craig, who leads the company’s sell-side M&A in primary care and behavioral health, shares his insights on investors working with fee-for-service healthcare groups. Some investors may find

    QHP Capital has announced it has acquired Applied StemCell.

    Applied StemCell, founded in 2008 and based in Milpitas, Calif., develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing.

    QHP, based in Raleigh, N.C., is a private equity firm that pursues investments in lower middle market healthcare

    Gov. Gavin Newsom recently signed into law the California Food Safety Act and amendments to the 2020 Toxic-Free Cosmetics Act. Together, they ban four additives commonly used in popular snacks and beverages, and an additional 26 chemicals found in many personal care products.

    Read on for details about these developments impacting food and personal care